Fennec Pharmaceuticals (FENC)

• Market cap: $258M
• 1 day: 0.8%
• 5 days: -0.53%
• 1 month: -2.96%
• 3 months: -13.81%
• 6 months: -9.25%
• Year to date: 20.03%
• 1 year: 23.57%
• 5 years: -0.4%
• 10 years: -37.08%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32